Dilip Shanghvi is not one for flamboyant statements or headline-grabbing moves. Yet, over the decades, the soft-spoken Chairman & Managing Director of Sun Pharma has turned the company from a ...

Dilip Shanghvi had said in February that the judgment was crucial for Sun Pharma's future course of action on this drug launch. "...the judgment is to validate the existing judgment, and we can't ...

According to market estimates, Leqselvi is projected to contribute $90 million to Sun Pharma's sales in FY26, and $125 million in FY27 ...

4.5 lakh crore. She’s also known as the daughter-in-law of Dilip Shanghvi, the founder and managing director of Sun Pharma, who is India’s wealthiest figure in the healthcare industry.

then we have to wait till December '26," Dilip Shanghvi, chairman and managing director of Sun Pharma, had said in an investor call in February. Also Read: Indian pharma companies escape Trump’s ...

Dilip Shanghvi, CMD, Sun Pharma had said earlier this year that the judgement was crucial for Sun Pharma’s future course of action on this drug launch. The company has been focussing on its ...

A lot has changed in India over the decades but not so much our attitude towards wealth and its creators. That is, until the ...

Industry leaders such as Dilip Shanghvi, managing director of Sun Pharma, previously indicated that if tariffs were levied, the costs would likely be passed on to consumers. “We have been ...

Sun Pharma chairman and managing director Dilip Shanghvi said: "Combining Unloxcyt…with Sun Pharma's global presence means patients with cSCC may soon have access to an important, new treatment ...

The net worth of Mukesh Ambani, Gautam Adani, Shiv Nadar, and others has taken a massive hit amid a sharp correction in ...